Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited

Pharma Wisdom provides job updates in the pharmaceutical, life science, and healthcare industries, facilitating recruitment efforts.

Pharma Wisdom

Lupin is a global pharmaceutical company based in India that develops, manufactures, and markets a wide range of generic and branded pharmaceuticals, including biosimilars and active pharmaceutical ingredients.

Metric
Company Name	Lupin Limited	Pharma Wisdom
Symbol	LUPIN
MSH ID	COM:LUPIN	IN:CO:PHARMAWISDOM
Market	STOCKS	PRIVATE
Sector	Healthcare	Commercial & Professional Services
Industry	Drug Manufacturers - Specialty & Generic	Healthcare
Country	IN	IN
Stage
Employee Count	20.93K
Website	lupin.com	pharmawisdom.co.in
LinkedIn
Founders

Metric
Market Cap	9.78B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	2.32B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.54B
EBITDA	464.06M
Operating Income	322.77M
Net Income	226.03M
EPS	0.50
Diluted EPS	0.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66
Operating Profit Margin	0.15
EBITDA Margin	0.20
Net Profit Margin	0.11
Return on Equity	0.19
Return on Assets	0.09
Return on Capital Employed	0.20

COM:LUPIN

Lupin

Last Close

2,071.35

25/11 09:40

Market Cap

828.54B

Beta: -

Volume Today

669.26K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	53.67
P/B Ratio	5.40
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.08
EV Multiple	23.57

Metric
Days Sales Outstanding	90.08
Days Payables Outstanding	147.84
Days Inventory Outstanding	272.17
Operating Cycle	360.10
Cash Conversion Cycle	197.58
Asset Turnover	0.85

Metric
Operating Cash Flow	430.73M
Free Cash Flow	321.06M
Cash Flow to Debt	0.53
Operating Cash Flow/Sales	0.08
Free Cash Flow Yield	0.00

Metric
Cash & Equivalents	116.09M
Accounts Receivable	-28.48M
Inventory	584.86M
Goodwill	274.50M
Debt to Capitalization	0.17
Debt to Assets	0.16
Current Ratio	1.41
Quick Ratio	1.00

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue
SG&A to Revenue